Godrej Industries Limited (GODREJIND)

Diversified · Diversified · NSE · Updated 15 July 2026
₹1,379.4 ↑ 22.96% (1Y)

🎯 Key Takeaways

  • Godrej Industries Limited is navigating a complex transition marked by financial volatility and strategic capital restructuring. The company exhibits cyclical performance with recent margin compression and net losses in Q4FY24, followed by partial recovery in Q3FY25, suggesting ongoing operational recalibration amid broader sectoral and economic headwinds.
  • Revenue grew 0.4% QoQ to ₹4,825 in Q3FY25.
  • ⚠️ Profitability remains volatile, as evidenced by the swing from ₹641 crore net profit in Q1FY25 to a ₹25 crore loss in Q4FY24, with operating margins f
Market Cap
₹38,229
P/E Ratio
27.0
Div Yield
0.00%
Promoter
0.0%

📖 The Story

Godrej Industries Limited is navigating a complex transition marked by financial volatility and strategic capital restructuring. The company exhibits cyclical performance with recent margin compression and net losses in Q4FY24, followed by partial recovery in Q3FY25, suggesting ongoing operational recalibration amid broader sectoral and economic headwinds.

📰 What's Happening

In Q1FY25, Godrej Industries reported revenue of ₹4,248 crore and net profit of ₹641 crore, but this was followed by a sharp decline in Q4FY24 with a loss of ₹25 crore, indicating inconsistent profitability. To strengthen its balance sheet, the company raised ₹1,000 crore through the private placement of non-convertible debentures in June 2026, with maturities scheduled for September and December 2031, carrying an 8.23% coupon. Additionally, it allotted 46,213 equity shares under its Employee Stock Grant Scheme, marginally increasing paid-up capital. Shareholder approval was secured for all resolutions via postal ballot in June 2026, including governance and board-related matters, though the departure of Independent Director Ajaykumar Vaghani may signal subtle governance shifts.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

MetricQ4FY23Q1FY24Q2FY24Q3FY24Q4FY24Q1FY25Q2FY25Q3FY25
Revenue4,8524,5063,9383,5904,5674,2484,8054,825
Operating Profit8336295855339941,345888919
OPM %12.4%5.4%6.7%7.8%10.0%7.9%12.0%12.4%
Net Profit562291165165-25641489312
EPS₹8.91₹5.29₹2.59₹3.16₹-9.26₹9.58₹8.54₹5.59

The company's financial trajectory shows pronounced volatility, with operating margins peaking at 12.4% in Q4FY23 and Q3FY25 but contracting to 7.8% in Q3FY24 before modest recovery. Net profit declined from ₹641 crore in Q1FY25 to a loss of ₹25 crore in Q4FY24, reflecting margin pressure and possible cost or volume headwinds. Despite this, revenue remained relatively stable around ₹4,800 crore in recent quarters, suggesting demand resilience in core segments. The sequential improvement in Q3FY25 from Q4FY24 losses indicates early signs of stabilization, though profitability remains sensitive to macro and operational variables.

🔮 Management Outlook & What's Next

Management has not provided explicit forward guidance in the reviewed filings; however, the issuance of ₹1,000 crore in NCDs with a 2031 maturity and proceeds earmarked for 'business needs, investments, and loan repayments' suggests a strategic focus on deleveraging and long-term capital planning. The capital raise underscores a proactive approach to balance sheet management, while the stable revenue base in recent quarters implies confidence in core business continuity. No dividend or buyback announcements were made, indicating capital allocation remains conservative and reinvestment-oriented.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Diversified

Company MCap (₹ Cr) P/E ROCE ROE D/E
Godrej Industries Limited 38,229 27.0
3M India Limited 35,198 57.6 38.4% 28.5% 0.00
DCM Shriram Limited 17,578 32.4
Kama Holdings Limited 8,456
Balmer Lawrie & Company Limited 3,327 12.6
TTK Healthcare Limited 1,268 21.1
Gillanders Arbuthnot & Company Limited 201 9400.0
Aspinwall and Company Limited 183 10.2

⚠️ Risk Factors

1. Profitability remains volatile, as evidenced by the swing from ₹641 crore net profit in Q1FY25 to a ₹25 crore loss in Q4FY24, with operating margins fluctuating significantly. 2. The departure of an Independent Director may raise concerns about board continuity and governance coherence, potentially affecting investor confidence. 3. High sensitivity to macroeconomic conditions is implied by inconsistent margin performance, particularly in core sectors like chemicals and real estate. 4. While debt raised is long-term and coupon is moderate, the company's ability to service obligations depends on sustained cash flow recovery, which remains unproven.

📋 Recent Filings

🧠 Analyst's Read

Godrej Industries is in a phase of operational and financial stabilization following a period of distress, with recent capital-raising activities aimed at strengthening liquidity and funding long-term initiatives. Investors should monitor upcoming earnings to assess whether margin and profit recovery sustains, while also watching for any strategic updates on capital allocation or business realignment. Governance changes and macro exposure remain key areas of focus.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

Sign Up Free — Unlock Full Analysis

2 free AI queries per day.

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-15.

📡 Get AI alerts when GODREJIND files new disclosures

Track GODREJIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GODREJIND — Free

Free account · 2 AI queries/day